1
Tagrisso 80mg tablet is for advanced non-small cell lung cancer with EGFR mutation positive patients, It is also used for the treatment of patients affected with advanced EGFR T792M mutation positive NSCLC, disease has advanced on or after the tyrosine kinase inhibitor treatment

Comments

Who Upvoted this Story

What is Plikli?

Plikli is an open source content management system that lets you easily create your own user-powered website.

Latest Comments